About Abecab 5 mg+40 mg Tablet

Abecab is a tablet that combines two blood pressure medicines, amlodipine and olmesartan medoxomil, in a strength of 5 mg + 40 mg. It is used to lower high blood pressure when a doctor decides a combination is suitable.

There are 18 brands of Amlodipine Besilate + Olmesartan Medoxomil listed in Bangladesh. 9 of them have a lower unit price than Abecab. The lowest listed price is Abecab 5 mg+20 mg Tablet at ৳ 12.00 per unit.

What is Abecab 5 mg+40 mg Tablet?

Abecab 5 mg+40 mg tablet is a combined antihypertensive preparation made by Advanced Chemical Industries PLC. It contains amlodipine besilate and olmesartan medoxomil. Amlodipine is a calcium channel blocker that relaxes the blood vessels, while olmesartan medoxomil works on a hormone system that tightens them. Together they help lower blood pressure. Doctors may prescribe this combination alone or with other blood pressure medicines, and sometimes as initial therapy for people likely to need more than one medicine. The doctor decides whether it suits a particular person.

Uses of Abecab

Abecab is used to treat hypertension, meaning high blood pressure. It may be used on its own or alongside other blood pressure medicines. In some patients whose blood pressure is likely to need more than one medicine to reach the goal, a doctor may choose this combination as initial therapy. Only the doctor can decide whether this medicine is appropriate and what target blood pressure to aim for.

How to use Abecab

Abecab is a tablet that is swallowed. The doctor decides the dose and how long it should be taken, based on the individual patient. Do not change the dose or stop taking it without the doctor's advice. If a dose is missed or there is doubt about how to take it, ask the doctor or pharmacist. Store it below 30°C, away from light and out of the reach of children.

Side effects of Abecab

Common side effects of this combination include swelling of the ankles or other peripheral edema, headache, flushing and dizziness. Some people may develop intestinal problems known as sprue-like enteropathy. If any side effect bothers you or does not go away, tell the doctor or pharmacist. Do not stop the medicine on your own; the doctor will advise what to do.

Safety and precautions

This combination should not be used in the second and third trimesters of pregnancy because it can harm the fetus, and it should be stopped as soon as pregnancy is detected. It is not known whether the ingredients pass into breast milk, so breastfeeding decisions need medical advice. It should be used with caution in people with low blood pressure from fluid or salt loss, severe aortic stenosis, or severe obstructive coronary artery disease. It must not be given with aliskiren to patients with diabetes. Ask the doctor first if any of these apply.

Frequently asked questions

What is Abecab used for and what kind of medicine is it?

Abecab is a combined antihypertensive tablet containing amlodipine and olmesartan medoxomil. It is used to lower high blood pressure, either alone or with other blood pressure medicines, when the doctor decides a combination is suitable.

How should Abecab be taken?

It is a tablet that is swallowed. The doctor decides the dose and the course, and may adjust it over time. Follow the doctor's instructions and do not change or stop the medicine on your own. Ask the doctor or pharmacist if anything is unclear.

Who should avoid Abecab or ask the doctor first?

Ask the doctor first if you are pregnant, planning pregnancy or breastfeeding, have low blood pressure from fluid or salt loss, severe aortic stenosis or severe coronary artery disease, or have diabetes and take aliskiren. The doctor will decide whether this medicine is suitable for you.

What is the price of Abecab?

The listed price is ৳ 20.00.

Indications

Abecab is indicated for the treatment of hypertension alone or with other antihypertensive agents, to lower blood pressure. This is indicated as initial therapy in patients likely to need multiple antihypertensive agents to achieve their blood pressure goals. The decision to use a combination as initial therapy should be individualized and shaped by considerations such as baseline blood pressure, the target goal, and the incremental likelihood of achieving goal with a combination compared to monotherapy. Individual blood pressure goals may vary based upon the patient’s risk.

Pharmacology

Amlodipine is a dihydropyridine calcium channel blocker that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. Amlodipine has a greater effect on vascular smooth muscle cells than on cardiac muscle cells. Amlodipine is a peripheral arterial vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure.

Angiotensin II formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE), is a potent vasoconstrictor, the primary vasoactive hormone of the Renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex.

Olmesartan Medoxomil blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor found in many tissues, (e.g. vascular smooth muscle, adrenal gland). In vitro binding studies indicate that Olmesartan Medoxomil is a reversible, competitive inhibitor of the AT1 receptor. Olmesartan Medoxomil does not inhibit ACE (kinase II, the enzyme that converts angiotensin I to angiotensin II and degrades bradykinin).

Dosage & Administration

Substitute individually titrated components for patients on Amlodipine and Olmesartan Medoxomil. This combination may also be given with increased amounts of Amlodipine, Olmesartan Medoxomil, or both, as needed.

Initial therapy: Initiate with 5/20 mg once daily for 1 to 2 weeks and titrate as needed up to a maximum of 10/40 mg once daily. Due to decreased clearance of Amlodipine among elderly patients the recommended starting dose of Amlodipine is 2.5 mg in patients 75 years. The lowest dose of the combination is 5/20 mg; therefore, initial therapy with this combination drug is not recommended in patients >75 years old.

Interaction

The antihypertensive effect of angiotensin II receptor antagonists, including Olmesartan Medoxomil may be attenuated by NSAIDs including selective COX-2 inhibitors. Blood pressure, renal function and electrolytes should be closely monitored in patients on combination therapy and other agents that affect the RAS.

Contraindications

Cannot be co-administered with Aliskiren in patients with diabetes.

Side Effects

The most common side effects include peripheral edema, headache, flushing, and dizziness. It can also cause Intestinal problems known a sprue-like enteropathy.

Pregnancy & Lactation

Pregnancy Category D. Amlodipine and Olmesartan Medoxomil combination should not be used in 2nd and 3rd trimester because it can cause fetal death. When pregnancy is detected this combination should be discontinued as soon as possible. It is not known whether Olmesartan and Amlodipine are excreted in human milk. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

Amlodipine and Olmesartan Medoxomil combination should be used with caution because there is a risk for-
  • Hypotension in volume- or salt depleted patients.
  • Vasodilation in patients with severe aortic stenosis.
  • Increased frequency, duration or severity of angina or acute Ml in patients with severe obstructive coronary artery disease.

Overdose Effects

There is no information on over dosage in humans.

Storage Conditions

Do not store above 30°C. Keep away from light and out of the reach of children.

Alternative brands of Amlodipine Besilate + Olmesartan Medoxomil

Other brands with the same generic name, cheapest first.

See all 18 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.